Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents

IF 6 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-01-17 DOI:10.1016/j.ejmech.2025.117286
Zi-Jie Song , Xiao-Fei Wu , Zhi-Ya Zhou , Jing-Jing Zhang , Yan-Yan Pan , Xue Dong , Xuan Pang , Ya-Ping Xie , Juan Sun , Yu Zhang , Jie Qin
{"title":"Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents","authors":"Zi-Jie Song ,&nbsp;Xiao-Fei Wu ,&nbsp;Zhi-Ya Zhou ,&nbsp;Jing-Jing Zhang ,&nbsp;Yan-Yan Pan ,&nbsp;Xue Dong ,&nbsp;Xuan Pang ,&nbsp;Ya-Ping Xie ,&nbsp;Juan Sun ,&nbsp;Yu Zhang ,&nbsp;Jie Qin","doi":"10.1016/j.ejmech.2025.117286","DOIUrl":null,"url":null,"abstract":"<div><div>A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as <strong>5a</strong>-<strong>5x</strong>), was synthesized and characterized through <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and <em>in vitro</em> anti-inflammatory activity. Notably, compound <strong>5l</strong> exhibited significant inhibition of both COX-2 and NO release <em>in vitro</em> in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). <strong>5l</strong> also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) <em>in vivo</em> comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound <strong>5l</strong> effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound <strong>5l</strong>. In conclusion, compound <strong>5l</strong> demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"286 ","pages":"Article 117286"},"PeriodicalIF":6.0000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425000510","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as 5a-5x), was synthesized and characterized through 1H NMR, 13C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and in vitro anti-inflammatory activity. Notably, compound 5l exhibited significant inhibition of both COX-2 and NO release in vitro in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). 5l also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) in vivo comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound 5l effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound 5l. In conclusion, compound 5l demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
羧酸取代塞来昔布异构体作为潜在抗炎剂的设计、合成和评价
合成了24个羧酸取代塞来昔布等构衍生物(标记为5a-5x),并通过1H NMR、13C NMR、HRMS和元素分析对其进行了表征。分子对接研究表明,所有化合物都成功地对接到COX-2的结合口袋中,羧基的引入增强了衍生物与COX-2的相互作用。进一步评价了这些化合物的细胞毒性和体外抗炎活性。值得注意的是,与标准化合物相比,化合物5l对COX-2酶和NO的体外释放均有显著的抑制作用,与塞来昔布(SI = 261.3)相比,化合物5l对COX-2酶的选择性最高(SI = 295.9)。5l在体内也表现出与塞来昔布相同浓度下最有效的抗炎活性和安全性(溃疡指数= 5.2)。通过分子建模和动力学分析,观察到化合物5l通过强氢键相互作用有效稳定在COX-2的活性结合位点内,并通过ADMET研究考察了化合物5l的理化性质和药物似然行为。总之,化合物5l被证明是一种潜在的选择性COX-2抗炎候选物,具有降低胃肠道风险的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Elucidating the Dual Mechanistic Action and Synergism of Platinum Complexes bearing Valproic Acid as Leaving Ligand on NF-κB and Inflammatory Pathways in Glioma Targeting Biofilm Formation in Candida albicans with Halogenated Pyrrolopyrimidine Derivatives Novel one-/two-photon excited carbazole/quinolinium photosensitizers manifest nanomolar and hypoxia-resistant tumor photodynamic therapy by accelerating apoptosis, ferroptosis, and autophagy Small molecule compounds targeting G9a/GLP: Recent advances and perspectives Design, synthesis and biological evaluation of Golgi-targeting anion transporters as inducers of Golgiphagy and apoptosis in cancer cells
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1